Designed for treatment of thermal burns, full-thickness trauma, and full-thickness surgical wounds, RECELL Spray-On Skin Cells support re-epithelialization, minimize or eliminate the need for large autografts, and contribute to shorter hospital stays that reduce overall cost burden – returning patients back to activities of daily living, faster.3-11
Scan for Instructions for Use. Visit avitamedical.com for Important Safety Information.
References: 1. Akpunonu C, et al. J Surg. 2025;10(07):11337. 2. Akpunonu C, et al. J Surg. 2025;10(05):11308. 3. Navarro FA, et al. J Burn Care Rehabil. 2000;21(6):513-518. 4. Collins ML, et al. J Surg Res. 2024;302:925-935. 5) Instructions for Use. RECELL® Autologous Cell Harvesting Device. 6) AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL. Press release. June 9, 2025. Accessed September 29, 2025. https://ir.avitamedical.com/news-releases/news-release-details/avita-medicalhighlights-largest-real-world-analysis 7) Holmes JH IV, et al. Burns. 2019;45(4):772-782. 8) Holmes JH IV, et al. J Burn Care Res. 2018;39(5):694-702. 9) Carter JE, et al. Adv Ther. 2022;39(11):5191-5202. 10) Carson JS, et al. Burns. 2023;49(3):607-614. 11) Henry S, et al. J Trauma Acute Care Surg. 2024;96(1):85-93.
©2026 AVITA Medical. AVITA Medical® , the AVITA Medical logo, RECELL® and Spray-On SkinTM Cells are trademarks of AVITA Medical. All other trademarks are the properties of their respective owners.
Products described on this website are not available in all countries. Regulatory approvals, indications for use, labeling, and product availability vary by jurisdiction. Please consult your local AVITA Medical representative or the applicable Instructions for Use for country-specific information.